A prospective, observational, single-center study in kidney transplant patients undergoing pre-exposure prophylaxis for COVID-19 with Tixagevi-mab/Cilgavimab
Latest Information Update: 23 Jan 2025
Price :
$35 *
At a glance
- Drugs Cilgavimab/tixagevimab (Primary)
- Indications COVID 2019 infections
- Focus Adverse reactions; Therapeutic Use
- 23 Jan 2025 New trial record